Prevalence of scars: an international epidemiological survey in adults

医学 疤痕 流行病学 皮肤病科 人口 瘙痒的 瘢痕疙瘩 真皮 痤疮 病理 外科 环境卫生
作者
J.-M. Amici,C. Taïeb,Caroline LeFloch,Anne‐Laure Demessant‐Flavigny,Sophie Seité,O. Cogrel
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:36 (10) 被引量:9
标识
DOI:10.1111/jdv.18277
摘要

Dear Editor, Skin is the most vulnerable organ that is constantly exposed to potential injury, and wound healing is a vital process for the survival of all higher organisms.1 Scarring is most noticeable in the skin, but it also affects almost all adult mammalian and human tissues and organs.2 They may result from surgery, skin injury, burning or inflammatory skin diseases, such as acne, chickenpox or shingles.3 Scars may be extensive, dystrophic, appearing on areas not covered by clothes and considered embarrassing. They may also be associated with symptoms such as pruritus, pain or other discomforts. According to a study conducted in the United Kingdom, 26% and 44% of patients reported pain and itching related to their scars, impacting their physical comfort and functioning.4 Usually, scars are composed of loose fibrous connective tissue and are remodelled during healing.5 Chronic inflammation of the dermis and uncontrolled activation of myofibroblasts may result in abnormal scar overgrowth leading to a hypertrophic scar or a keloid with an excess of extracellular matrix proteins.6 Despite being common throughout the world, the epidemiology of scars has not yet been properly investigated. The aim of this international epidemiological study was to assess the prevalence of scars worldwide. The present article describes the general population with participants reporting at least one scar having appeared during the year prior to this study. Our participants were selected via a stratified random sampling method of internet users who agreed to participate in panel surveys. Data about sociodemography, presence, origin and symptoms of scars using an internet survey were collected between April and May 2020. The survey focused on the most recent scars reported in order to simplify data collection. Overall, 11 100 individuals from Brazil (2000), China (3050), France (2000), Russia (2000) and the United States (2050) answered the survey; 48.5% of subjects reported at least one scar, and in 22%, the most recent scar was less than one-year-old. The most often reported location of recent scars in women was the abdomen (20.4%) and face (15.9%); in men, it was the face (18.7%) and abdomen (13.2%). Significantly more men (13.3%, P < 0.00001) than women (8.4%) reported scars on their hands. For 50.8%, the origin of the most recent scar was accidental or due to a disease (women: 50.8%, men: 60.5%, P < 0.0001); 35% of women and 28% of men indicated that general or orthopaedic surgery caused the scarring (P < 0.0001). Details are given in Table 1. Overall, 12.3% of men and 10.7% of women who reported scars also reported pain (P < 0.03). Table 2 provides details about symptoms. In 2014, international guidelines on the management of scars were issued. However, these guidelines have not yet been updated.7, 8 Currently, some procedures are available to manage scars, such as intralesional injections of corticosteroids and/or 5-fluorouracil, cryotherapy, radiotherapy, laser therapy and surgical interventions, together with additional measures such as sun protection, silicone-based dressings or gels.9, 10 Scar management mainly consisted in the use of topical products such as healing creams (13.2%), antiseptic solutions (11.2%) or a topical antibiotic (11.9%). Medical care was significantly (P < 0.001) more frequently provided to subjects with painful scars. To our knowledge, this is the first international epidemiological survey on the prevalence, origin, location and impact of scars. Further investigations need to be performed. The authors acknowledge the technical support of G. Le Dantec and the writing support of Karl Patrick Goritz, SMWS—Scientific and Medical Writing Services, France. This project was funded by La Roche Posay. S. Seité, AL Demessant-Flavigny and C. LeFloc'h are employees of La Roche-Posay. The data that support the findings of this study are available from the corresponding author upon reasonable request. The data that support the findings of this study are available from the corresponding author upon reasonable request.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI

祝大家在新的一年里科研腾飞
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
岁月轮回完成签到,获得积分10
刚刚
CipherSage应助伯赏汝燕采纳,获得20
1秒前
HEIKU应助lily336699采纳,获得10
2秒前
星辰大海应助危机的茗采纳,获得10
2秒前
kk发布了新的文献求助10
4秒前
5秒前
可靠的寒风完成签到,获得积分10
7秒前
FashionBoy应助小朱同学采纳,获得10
9秒前
9秒前
devilito发布了新的文献求助10
11秒前
12秒前
12秒前
13秒前
拓跋康发布了新的文献求助10
13秒前
14秒前
MY999发布了新的文献求助10
14秒前
串串完成签到,获得积分10
14秒前
乐乐应助kk采纳,获得10
15秒前
大号安全蛋完成签到,获得积分10
15秒前
科研通AI2S应助见过采纳,获得10
16秒前
17秒前
伯赏汝燕发布了新的文献求助20
17秒前
17秒前
xiaoZ发布了新的文献求助10
18秒前
是你的雨发布了新的文献求助10
18秒前
赘婿应助串串采纳,获得10
19秒前
Maestro_S应助月牙湾采纳,获得20
19秒前
20秒前
20秒前
Owen应助cc采纳,获得10
21秒前
尊敬伟宸发布了新的文献求助10
22秒前
所所应助水值采纳,获得10
22秒前
领导范儿应助兮兮采纳,获得10
23秒前
Jerry20184完成签到 ,获得积分10
26秒前
科研通AI2S应助驰月采纳,获得10
27秒前
27秒前
li发布了新的文献求助10
29秒前
29秒前
JamesPei应助杏杏采纳,获得10
29秒前
31秒前
高分求助中
Востребованный временем 2500
The Three Stars Each: The Astrolabes and Related Texts 1500
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
Les Mantodea de Guyane 800
Mantids of the euro-mediterranean area 700
The Oxford Handbook of Educational Psychology 600
有EBL数据库的大佬进 Matrix Mathematics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 内科学 纳米技术 物理 计算机科学 化学工程 基因 复合材料 遗传学 物理化学 免疫学 细胞生物学 催化作用 病理
热门帖子
关注 科研通微信公众号,转发送积分 3416011
求助须知:如何正确求助?哪些是违规求助? 3017735
关于积分的说明 8882350
捐赠科研通 2705345
什么是DOI,文献DOI怎么找? 1483501
科研通“疑难数据库(出版商)”最低求助积分说明 685735
邀请新用户注册赠送积分活动 680742